Skip to main content
Izel Erdogan on Muck Rack

Izel Erdogan

As seen in: medRxiv
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Izel

Contact Izel, search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Unravelling the joint genetic architecture between psychiatric and insulin-related traits in the general population

|
By Izel Erdogan, Giuseppe Nicolò Fanelli, Martina Arenella, Barbara Sakic
| medRxiv
The authors have declared no competing interest. This publication is part of the project No labels needed: understanding psychiatric disorders based on genetic traits (with project number 09150161910091) of the research program Veni, which is partly financed by the Dutch Research Council (NWO) Health Research and Development (ZonMW).
Open in Who Shared Issue with article?

The multivariate genetic architecture of psychiatric and insulin resistance multimorbidity

|
By Nina Roth Mota, Giuseppe Nicolò Fanelli, Marieke Klein, Izel Erdogan
| medRxiv
IHR is an employee and GP is the director and chief scientific officer of Drug Target ID, Ltd., but their activities at this company do not constitute competing interests with regard to this paper. AS has served as a consultant or speaker for Abbott, Abbvie, Angelini, AstraZeneca, Clinical Data, Boehringer, Bristol-Myers Squibb, Eli Lilly, GlaxoSmithKline, Innovapharma, Italfarmaco, Janssen, Lundbeck, Naurex, Pfizer, Polifarma, Sanofi, and Servier and Taliaz.
Open in Who Shared Issue with article?
See all 2 articles